Results from short-, medium- and long-term follow-up
| Follow-Up and Patients | Outcome with O2-O3 | Outcome with Steroid | ||||
|---|---|---|---|---|---|---|
| Excellent | Good | Poor | Excellent | Good | Poor | |
| Short term | ||||||
| With disk disease (n = 166) | 73 (84.8%) | 8 (9.3%) | 5 (5.9%) | 64 (80%) | 10 (12.5%) | 8 (10%) |
| Without disk disease (n = 160) | 56 (80%) | 11 (15.7%) | 3 (4.3%) | 55 (78.5%) | 9 (12.8%) | 5 (7.2%) |
| Medium term | ||||||
| With disk disease (n = 166) | 67 (77.9%) | 9 (10.5%) | 10 (11.6%) | 54 (67.5%) | 14 (17.5%) | 12 (15%) |
| Without disk disease (n = 160) | 55 (78.5%) | 9 (12.9%) | 6 (8.6%) | 49 (70%) | 10 (14.2%) | 11 (15.8%) |
| Long term | ||||||
| With disk disease (n = 166) | 64 (74.4%) | 9 (10.5%) | 13 (15.1%) | 46 (57.5%) | 16 (20%) | 18 (22.5%) |
| Without disk disease (n = 160) | 53 (75.8%) | 11 (15.7%) | 6 (8.6%) | 44 (62.8%) | 11 (15.8%) | 15 (21.4%) |
Note.—Data in parentheses are percentages. Short term = 1 week, medium term = 3 months, and long term = 6 months.